Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Dapagliflozin for treating chronic heart failure with reduced ejection fractionNational Institue for Health and Care Excellence -
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patientsZacharias M1, Joffe S, Goldberg RJ et al.
-
Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch BlockOJ Sletten, JM Aalen, H Izci et al.
-
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart FailureMcMurray JJ, Krum H, ATMOSPHERE Committees Investigators.
-
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunctionGoldberg LR, Jessup M.
-
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist SystemsBerg DD, Vaduganathan M, Stewart GC et al.
-
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced TrialSD Anker, J Butler, EMPEROR-Reduced Trial Committees and Investigators et al.
-
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionSD Solomon, the PARAGON-HF Investigators and Committees. JohnJV McMurray,
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
